Vimarsana
Biggest News Aggregation in the World

Page 15 - Hpcsa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hpcsa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hpcsa Today - Breaking & Trending Today

Ekurhuleni man nabbed for fraud after submitting fake doctor's note to employer - Vimarsana News

Ekurhuleni man nabbed for fraud after submitting fake doctor's note to employer

An Ekurhuleni man who allegedly submitted a fake doctor's note to his employer has been charged with fraud, the Health Professions Council of South Africa’s (HPCSA) said on Friday

Speech therapy students face extra year of study as Fort Hare says 'aikhona - Vimarsana News

Speech therapy students face extra year of study as Fort Hare says 'aikhona

A group of students studying speech-language therapy at the University of Fort Hare are accusing the institution of offering a low-standard course barring them from graduating.

Hello Doctor, bye bye queues: 24/7 phone service cuts clinic waiting times - Vimarsana News

Hello Doctor, bye bye queues: 24/7 phone service cuts clinic waiting times

Instead of schlepping to the clinic, patients can access medical advice and be triaged at the tap of a finger

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Short Interest Update - Vimarsana News

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Short Interest Update

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 123,500 shares, an increase of 31.9% from the May 15th total of 93,600 shares. Currently, 1.1% of the company’s shares are sold short. Based […]

Analysts Expect Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Will Post Earnings of -$0.26 Per Share - Vimarsana News

Analysts Expect Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Will Post Earnings of -$0.26 Per Share

Brokerages predict that Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) will announce earnings of ($0.26) per share for the current quarter, Zacks reports. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals posted earnings per share of ($0.20) in the same quarter last year, which would indicate a negative year-over-year growth rate of […]